FISHMAN COREY N. (President & CEO) sold 21.0% of their position (85.44K shares) of ITERUM THERAPEUTICS PLC on the open market
Open‑market sale worth $147.8K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/27/2021ACC: 0000899243-21-003521
DirectorOfficer· President & CEO
Since Aug 2018
+82.06K
Net shares
Net buyer
$147.8K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
167.50K acquired · 85.44K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+167.50K
Price / share
—
Trade value
—
% of position
69.8%
1/25/2021
239.95K→407.45K
Ordinary Shares
Direct
Shares
−85.44K
Price / share
$1.73
Trade value
$147.82K
% of position
21.0%
1/26/2021
407.45K→322.01K
Total
Net shares
+82.06K
Net value
-$147.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 1/25/2021 | A · Award | +167.50K | — | — | 69.8% | 239.95K | 407.45K |
| Ordinary Shares Direct | 1/26/2021 | S · Sale | −85.44K | $1.73 | $147.82K | 21.0% | 407.45K | 322.01K |
| Total | +82.06K | -$147.82K | ||||||
Derivative Transactions0
No derivative transactions reported